Peter Doshi

Peter Doshi holds dual institutional affiliations:

• Assistant Professor, Department of Pharmaceutical Health Services, University of Maryland
• Associate Editor, The BMJ

His research specializes in drug safety and effectiveness evaluation within regulatory frameworks, with a core focus on evidence synthesis methodologies. He is a leading advocate for public access to clinical trial data, leveraging medical journalism to enhance research integrity. Since 2009, Dr. Doshi has spearheaded analysis of approximately 150,000 pages of internal pharmaceutical company documents to evaluate anti-influenza medications including Tamiflu, significantly contributing to transparency debates in pharmaceutical regulation.